![Robert More](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert More
Président chez
TYRA BIOSCIENCES, INC.
Fortune : 495 805 $ au 30/06/2026
Profil
Robert J.
More is currently Chairman at Affinivax, Inc. and Tyra Biosciences, Inc. (since 2019).
He is Managing Director at Alta Partners Management Co. LP.
He serves as Director at Acureon Pharmaceuticals, Inc., Biotechnology Innovation Organization, Sirenas LLC, Nuon Therapeutics, Inc., Variant Bio, Inc., MBrace Therapeutics, Inc., Kelonia Therapeutics, Inc., Amplitude Therapeutics, Inc., and holds the position of Independent Director at Vir Biotechnology, Inc. (since 2016).
Former roles include Chairman at Intercept Pharmaceuticals, Inc. Director positions at TargetRx, Inc., ESP Pharma, Inc., Receptor BioLogix, Inc., AMO Development LLC, PatientKeeper, Inc., Achaogen, Inc., NovaCardia, Inc., Esprit Pharma, Inc., Foundation for Innovative New Diagnostics, Apnex Medical, Inc., One Revolution Entertainment LLC, Cytyc Surgical Products II, Inc., Oceana Therapeutics, Inc., Neothetics, Inc., Moximed, Inc., Cartiva, Inc., eGenesis, Inc., Hangzhou Qihan Biotech Co., Ltd., Proxima Therapeutics, Inc., Sienna Biopharmaceuticals, Inc. (Independent Director), Society of Kauffman Fellows, and others.
He was Director at Glaukos Corp.
from 2001 to 2015, Director at Carticept Medical, Inc. from 2005 to 2010, General Partner at Frazier Management LLC from 2008 to 2013, Partner at Domain Associates LLC from 1996 to 2008, Chief Operating Officer at Morphochem, Inc., and Senior Advisor at Bill & Melinda Gates Foundation Trust (Investment Management).
Education includes an undergraduate degree from Middlebury College (1989) and an MBA from the University of Virginia Darden School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/05/2026 | 48 656 ( 0,03% ) | 495 805 $ | 30/06/2026 | |
TYRA BIOSCIENCE, INC -.--% | 28/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Robert More
| Sociétés | Poste | Début |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 01/09/2016 |
| TYRA BIOSCIENCES, INC. | Président | 01/03/2019 |
Sirenas LLC
 Sirenas LLC Pharmaceuticals: MajorHealth Technology Develops proprietary drug discovery technology | Directeur/Membre du Conseil | - |
Affinivax, Inc.
 Affinivax, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel conjugation technology | Président | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Kelonia Therapeutics, Inc.
 Kelonia Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops pipeline of genetic medicines | Directeur/Membre du Conseil | - |
Mbrace Therapeutics, Inc.
 Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Provides drug discovery and development services for cancer treatment | Directeur/Membre du Conseil | - |
Variant Bio, Inc.
 Variant Bio, Inc. BiotechnologyHealth Technology Develops therapeutics for human generic diversity | Directeur/Membre du Conseil | - |
Acureon Pharmaceuticals, Inc.
 Acureon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops & markets therapeutics for infectious diseases | Directeur/Membre du Conseil | - |
| ░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Anciens postes connus de Robert More
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Robert More
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
42
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 42 |
|---|---|
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Finance |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners invests in companies located in the United States. The firm focuses on life sciences and healthcare technology services sectors. It participates in seed, early and later stage capital transactions. It acts as the lead investor and takes a seat on board of directors. | Finance |
TargetRx, Inc.
 TargetRx, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing consultancy services | Commercial Services |
ESP Pharma, Inc.
 ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical products | Health Technology |
Receptor BioLogix, Inc.
 Receptor BioLogix, Inc. BiotechnologyHealth Technology Offers receptor based biological therapeutics | Health Technology |
AMO Development LLC
 AMO Development LLC Medical SpecialtiesHealth Technology Designs, develops and manufactures femtosecond laser technology for use in ophthalmology | Health Technology |
PatientKeeper, Inc.
 PatientKeeper, Inc. Packaged SoftwareTechnology Services Provides healthcare applications for physicians | Technology Services |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cardiovascular diseases | Health Technology |
Esprit Pharma, Inc.
 Esprit Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Foundation for Innovative New Diagnostics
 Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Provides diagnostic tests for poor people | Health Services |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Acureon Pharmaceuticals, Inc.
Acureon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops & markets therapeutics for infectious diseases | Retail Trade |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Glaukos Corp.
 Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
Apnex Medical, Inc.
 Apnex Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and markets medical devices | Health Technology |
One Revolution Entertainment LLC | |
Sirenas LLC
Sirenas LLC Pharmaceuticals: MajorHealth Technology Develops proprietary drug discovery technology | Health Technology |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors. | Finance |
Morphochem, Inc.
 Morphochem, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs | Health Technology |
Middlebury College
 Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytyc Surgical Products II, Inc.
 Cytyc Surgical Products II, Inc. Medical SpecialtiesHealth Technology Manufactures and sells medical devices | Health Technology |
Carticept Medical, Inc.
 Carticept Medical, Inc. Medical SpecialtiesHealth Technology Develops and markets medical devices | Health Technology |
Nuon Therapeutics, Inc.
 Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammation and neurological diseases | Health Technology |
Society of Kauffman Fellows
 Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services Operates as a network of venture capitalists | Commercial Services |
Oceana Therapeutics, Inc.
 Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and medical devices | Health Technology |
Neothetics, Inc.
 Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic | Health Technology |
Moximed, Inc.
 Moximed, Inc. Medical SpecialtiesHealth Technology Develops medical device treatments | Health Technology |
Cartiva, Inc.
 Cartiva, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices | Health Technology |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bill & Melinda Gates Foundation Trust (Investment Management)
 Bill & Melinda Gates Foundation Trust (Investment Management) Investment Trusts/Mutual FundsMiscellaneous Gates Foundation-IM holds the endowment, including the annual installments of Warren Buffett’s gift, and funds the foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed, as it has been for almost three decades, by a team of outside investment managers. The Trust invests in undistributed assets, with the exclusive goal of maximizing the return on investment. Investments include companies that have been criticized for worsening poverty in the same developing countries where the foundation is attempting to relieve poverty. The majority of the trust's assets are invested in government and corporate bonds, with additional holdings in commercial paper and other short-term debt securities. The trust engages in substantial foreign currency transactions, options and futures trading and lending out of securities. | Miscellaneous |
Affinivax, Inc.
Affinivax, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel conjugation technology | Health Technology |
Sienna Biopharmaceuticals, Inc.
 Sienna Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | Health Technology |
eGenesis, Inc.
 eGenesis, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology company that provides organs and cells transplantation services | Health Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Hangzhou Qihan Biotech Co., Ltd.
 Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Tyra Biosciences, Inc.
 Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
Variant Bio, Inc.
Variant Bio, Inc. BiotechnologyHealth Technology Develops therapeutics for human generic diversity | Health Technology |
Proxima Therapeutics, Inc.
 Proxima Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops radiation delivery systems for the treatment of solid cancerous tumor | Commercial Services |
Mbrace Therapeutics, Inc.
Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Provides drug discovery and development services for cancer treatment | Health Technology |
Kelonia Therapeutics, Inc.
Kelonia Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops pipeline of genetic medicines | Health Technology |
Amplitude Therapeutics, Inc.
 Amplitude Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology firm that researches ribonucleic acid medicines | Health Technology |
